Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLB1 | P16278 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19425953 | 1.00 | GLB1 (0.40) | GLB1HPGDALDH1A1 | |
| SCHEMBL12855090 | 1.00 | GLB1 (0.40) | GLB1HPGDALDH1A1 | |
| SCHEMBL12838253 | 1.00 | GLB1 (0.40) | GLB1HPGDALDH1A1 | |
| SCHEMBL20756353 | 0.91 | GLB1 (0.37) | GLB1 | |
| SCHEMBL9884607 | 0.85 | GLB1 (0.34) | GLB1 | |
| SCHEMBL10072459 | 0.80 | GLB1 (0.37) | GLB1 | |
| SCHEMBL12386673 | 0.80 | GLB1 (0.37) | GLB1 | |
| SCHEMBL14853747 | 0.80 | GLB1 (0.40) | GLB1HPGDALDH1A1 | |
| SCHEMBL16658852 | 0.80 | GLB1 (0.37) | GLB1 | |
| SCHEMBL17972490 | 0.80 | GLB1 (0.37) | GLB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210379253-A1 | IMMOBILISED BIOLOGICAL ENTITIES | CARMEDA AB (SE) | 2021-12-09 | — | — | US | disclosed |
| US-10912838-B2 | Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same | THE UNIVERSITY OF TOKYO (JP) | 2021-02-09 | — | — | US | disclosed |
| WO-2020070258-A1 | IMMOBILISED BIOLOGICAL ENTITIES | CARMEDA AB (SE) | 2020-04-09 | — | — | WO | disclosed |
| US-20180185501-A1 | CARRIER FOR USE IN DELIVERING DRUG, CONJUGATE, COMPOSITION COMPRISING SAME, AND METHOD FOR ADMINISTRATING SAME | THE UNIVERSITY OF TOKYO (JP) | 2018-07-05 | — | — | US | disclosed |
| US-9937263-B2 | Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same | THE UNIVERSITY OF TOKYO (JP) | 2018-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180185501-A1 | CARRIER FOR USE IN DELIVERING DRUG, CONJUGATE, COMPOSITION COMPRISING SAME, AND METHOD FOR ADMINISTRATING SAME | SLC2A1, SLC2A4, SLC2A2 | GLB1 1952/4885HPGD 3970/4885ALDH1A1 726/4885 |
| US-10912838-B2 | Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same | SLC2A1, SLC2A4, SLC2A2 | GLB1 1952/4885HPGD 3970/4885ALDH1A1 726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.